Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial
Roche Pharmaceuticals' CEO told investors she was "serious" about the goal of becoming a top 3 obesity player.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Roche
since
auto-detected in 17 stories
73 days ago
4 months ago
Trump's pharmaceutical tariffs could affect some drugmakers more than others
found
AbbVie, Bristol Myers Squibb and Eli Lilly appear "relatively well-positioned," while Novartis and Roche look more at risk, TD Cowen analyst Steve Scala said.
Prince William and Harry's cousin, 20, found dead 'with firearm nearby'
found
a story from The Daily Mail 💩 › The Daily Mail
Rosie Roche, 20, who was the granddaughter of Princess Diana's uncle, died at her family home on July 14. The 20-year-old was found by her mother and sister.
6 months ago
Murderer freed from prison early because he was 'polite' stabbed his great-uncle to death less than a year later
Direece Roche, 30, was released in 2023 after serving 12 years of a life sentence imposed in 2011 for stabbing an innocent bystander to death outside a New Year's Day party.
7 months ago
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's "next generation" weight loss drug.
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's "next generation" weight loss drug.
Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs
found
a story from The Guardian ⚠️ › International
Company says it will create 12,000 jobs in manufacturing and R&D over next five years
- Business live – latest updates
The Swiss drugmaker Roche has said it will put $50bn (£37bn) into manufacturing in t…
Roche to invest $50 billion in the U.S. as pharma tariff threat lingers
Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the United States.
Roche to invest $50 billion in the U.S. as pharma tariff threat lingers
Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the United States.
Roche to invest $50 billion in the U.S. as pharma tariff threat lingers
Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the United States.